• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    27.75 -1.48 (-5.06%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,735,692
    Open 28.66
    Bid (Size) 27.75 (600)
    Ask (Size) 27.94 (100)
    Prev. Close 29.23
    Today's Range 27.61 - 29.09
    52wk Range 22.96 - 43.15
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188% ↗
    If you look beyond the upside potential, there's still plenty of risk to navigate past. 
    Via The Motley Fool
    News headline image
    1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
    This particular sector may suit cautious and aggressive investors. 
    Via The Motley Fool

    Performance

    YTD
    -21.7%
    -21.7%
    1 Month
    -12.5%
    -12.5%
    3 Month
    -19.9%
    -19.9%
    6 Month
    -25.6%
    -25.6%
    1 Year
    +0.7%
    +0.7%

    More News

    Read More
    News headline image
    Bull vs. Bear: The Quick Take on Viking Therapeutics Stock ↗
    Via The Motley Fool
    Viking Therapeutics (NASDAQ:VKTX) Stock Holds Steady After Q1 2026 Earnings Miss on Higher Phase 3 Spending ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside Down ↗
    Via The Motley Fool
    News headline image
    The Smartest Growth Stocks to Buy With $2,000 Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Prediction: These 2 Obesity Drug Stocks Could Double in 2026 ↗
    Via The Motley Fool
    News headline image
    Don't Buy Viking Therapeutics Stock Until You Read This ↗
    Via The Motley Fool
    News headline image
    Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know. ↗
    Via The Motley Fool
    News headline image
    Is Viking Therapeutics a Top Takeover Target? ↗
    Via The Motley Fool
    News headline image
    2 Stocks That Could Realistically Double by 2030 ↗
    Via The Motley Fool
    News headline image
    Could Viking Therapeutics Be the Next Eli Lilly? ↗
    Via The Motley Fool
    News headline image
    Best Weight Loss Drug Stocks to Buy in 2026 ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party ↗
    Via The Motley Fool
    News headline image
    Eli Lilly Stock: Next Stop $2,000? ↗
    Via The Motley Fool
    News headline image
    Should Eli Lilly Investors Worry About Its Newest Rival -- From Within? ↗
    Via The Motley Fool
    Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
    Via Investor Brand Network
    InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
    Via Investor Brand Network
    News headline image
    Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗
    Via The Motley Fool
    News headline image
    Eli Lilly Just Announced Fantastic News for Shareholders ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗
    Via MarketBeat
    News headline image
    Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗
    Via The Motley Fool
    News headline image
    This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 27.75
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 06/10/26 04:00 PM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.76B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.